Analyst Ratings for SciClone Pharmaceuticals (SCLN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/8/2017 | Maxim Group | N/A | Downgrade | Hold (Buy) |
N/A (N/A) |
10.10 (11.15) |
10.4% | Details |
| 7/16/2013 | Aegis Capital » Updated 1/6/2015 |
N/A | Upgrade | Buy (Hold) |
10.00 (N/A) |
5.67 (11.15) |
96.65% | Details |
 |
||||||||
|
||||||||
